Efficacy of an integrated approach encompassing pregabalin and mirror therapy in management of complex regional pain syndrome type 1- A pilot study.

niversity College of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients having chronic continuous pain, which is disproportionate to any inciting event with diagnosis of CRPS type 1, as confirmed by-
•Budapest criteria of CRPS for clinical use (IASP 2016)
•Must report at least one symptom in three of the four following categories:
•Sensory: reports of hyperesthesia and/or allodynia
•Vasomotor: reports of temperature asymmetry and/or skin color changes and/or skin color asymmetry.
•Sudomotor: reports of edema and/or sweating changes and/or sweating asymmetry.
•Motor/trophic: reports of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin).
•Must display at least one sign at the time of evaluation in two or more of the following four categories:
•Sensory: Evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch and/or deep somatic pressure, allodynia to innocuous cold (25 â?¦C) or innocuous warm (40 â?¦C), and/or joint movement).
•Vasomotor: evidence of temperature asymmetry and/or skin color changes and/or skin color asymmetry.
•Sudomotor/edema: evidence of edema and/or sweating changes and/or sweating asymmetry.
•Motor/trophic: evidence of decreased range of motion and/or motor dysfunction (weakness, tremor, dystonia) and/or trophic changes (hair, nails, skin).

•The presence of pain at any other site due to any other cause.
•An intra-articular injection into the joints during the previous 6 months or use of systemic corticosteroids during the previous 4 months;
•Uncontrolled co-morbid medical conditions;
•Cognitive impairments that might interfere with understanding instructions for various questionnaires, motor testing, and treatment.

发起方

niversity College of Medical Sciences